Locquet, M., Beaudart, C., Pétermans, J., Reginster, J., & Bruyère, O. (2019). EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences.
Citazione stile Chigago Style (17a edizione)Locquet, Médéa, Charlotte Beaudart, Jean Pétermans, Jean‐Yves Reginster, e Olivier Bruyère. EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences. 2019.
Citatione MLA (9a ed.)Locquet, Médéa, et al. EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences. 2019.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.